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Indoleamine 2,3-dioxygenase (IDO) is found in the
majority of human tumors and has been described as an
important contributor to the development of an immuno-
suppressive tumor microenvironment that blocks the
action of cytotoxic antitumor effector T cells. In order to
delineate the mechanisms of IDO-induced immunosup-
pression in melanoma, we initially focused on murine
transplantable and spontaneous melanoma models. We
find that while murine melanomas did not naturally
express high levels of IDO, IDO expression could be
induced in the tumor cells within the context of the tumor
microenvironment in vivo. In order to examine the role of
IDO on the melanoma tumor microenvironment and its
effect on tumor progression, we generated B16 melanoma
cell lines overexpressing IDO (B16-IDO). When implanted
into mice, B16-IDO tumors exhibited aggressive tumor
growth, characterized by more rapid tumor progression
and local invasion, when compared to the native B16 cells.
Furthermore, constitutive expression of IDO by B16 cells
conferred resistance to T-cell-targeting immunotherapies,
such as treatment with CTLA-4 and PD-1 blocking anti-
bodies. Interestingly, the immunosuppressive effect of
IDO overexpression was evident not just within the
tumor, but systemically as well. Analysis of the tumors in
vivo, showed that this effect was accompanied by changes
favoring a highly inhibitory tumor microenvironment
characterized by significant reduction on local tryptophan
concentrations and lack of effector T cells at the tumor
site. The effect of IDO overexpression on immunosup-
pressive cell populations of the tumor microenvironment
such as regulatory T cells and myeloid-derived suppressor
cells will be further characterized. Our study thus defines
IDO expression as an important mechanism driving the
institution of an inhibitory tumor microenvironment and
tumor progression, and provides a strong rationale for
therapeutic targeting of this pathway.
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